Third cranial nerve palsy in an 88-year-old man after SARS-CoV-2 mRNA vaccination: change of injection site and type of vaccine resulted in an uneventful second dose with humoral immune response

Vaccines for SARS-CoV-2 currently authorised by the European Medicine Agency are effective, safe and well tolerated in practice. Awareness of rare potential vaccine-related adverse effects (AEs) is important to improve their recognition, management and reporting. An 88-year-old man attended the emer...

Descripción completa

Detalles Bibliográficos
Autores principales: Cicalese, Maria Pia, Ferrua, Francesca, Barzaghi, Federica, Cerri, Federica, Moro, Matteo, Aiuti, Alessandro, Silvani, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830097/
https://www.ncbi.nlm.nih.gov/pubmed/35135792
http://dx.doi.org/10.1136/bcr-2021-246485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830097/
https://www.ncbi.nlm.nih.gov/pubmed/35135792
http://dx.doi.org/10.1136/bcr-2021-246485

Ejemplares similares